Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:18 PM ET 8-K
Financial Results Northern Oil & Gas, Inc. NOG

Northern Oil & Gas Financial Results

Northern Oil and Gas reported record Q3 2026 results with production reaching 156,239 Boe per day and record Adjusted EBITDA of $444.5 million. Despite a GAAP net loss of $111.8 million due to derivative mark-to-market losses, the company generated $148.6 million in free cash flow and raised its full-year production guidance.

Term
Q3 2026

“The third quarter was a record for NOG, and the drivers matter as much as the results. We set new highs for total production, natural gas volumes and Adjusted EBITDA, and generated nearly $150 million of Free Cash Flow even as activity increased across our oil-weighted basins.”

Nick O’Grady, Chief Executive Officer

“With every region performing, we are raising full-year production guidance while holding our capital budget unchanged. Put simply, we expect to deliver more for the same capital.”

Nick O’Grady, Chief Executive Officer
4:18 PM ET 10-Q
Financial Results Alector, Inc. ALEC

Alector Q3 2026 Results: Turns Profitable, Net Income $125M

Alector, Inc. reported a significant increase in collaboration revenue to $167.2 million for the nine months ended September 30, 2026, compared to $14.8 million in the prior year, resulting in a net income of $78.7 million. This turnaround from a net loss in 2025 was driven by the recognition of deferred revenue, while operating expenses decreased from $131.2 million to $92.7 million.

Key figure
Net income $125M
4:18 PM ET 10-Q
Financial Results Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics Q3 2026 Results: Net Loss of $127M, Loss Widens

Intellia Therapeutics reported a net loss of $127.5 million for the third quarter of 2026, driven by a decrease in collaboration revenue and increased general and administrative expenses. The company strengthened its balance sheet during the nine months ended September 30, 2026, through a follow-on public offering and new debt issuance, resulting in total cash, cash equivalents, and marketable securities of approximately $614.8 million.

Key figure
Net loss $127M
4:18 PM ET 10-Q
Financial Results In8Bio, Inc. INAB

In8Bio Q3 2026 Results: Net Loss of $4.59M, Loss Widens

IN8BIO, INC. reported a net loss of $14.5 million for the nine months ended September 30, 2026, which was consistent with the prior year period. The company's cash position decreased significantly from $27.1 million at the end of 2025 to $14.0 million as of September 30, 2026, primarily due to $12.6 million used in operating activities.

Key figure
Net loss $4.59M
4:18 PM ET Form 4
Insider Buying Varonis Systems Inc VRNS

Varonis Systems Insider Rachel Prishkolnik Buys $26.1K of Stock

Rachel Prishkolnik bought 1,015 shares of Varonis Systems Inc at $25.72 a share, worth $26.1K in total on Feb 19, 2026. Shares held after the trade: 33,953 (+3.1%).

Value
$26.1K
Shares
1,015
Price
$25.72
Holding change
+3.1%
Trade date
Feb 19, 2026
4:18 PM ET 8-K
Financial Results Nerdwallet, Inc. NRDS

Nerdwallet Financial Results

NerdWallet reported Q3 2026 revenue of $239.6 million, an 11% increase year-over-year, driven by strong growth in consumer revenue from student loans and personal loans. The company achieved GAAP net income of $14.9 million and Adjusted EBITDA of $39.8 million, despite a year-over-year decline in operating income.

Term
Q3 2026

“Providing clarity for all of life’s financial decisions is how we earn the trust of the consumers and small businesses we serve. We’re building on that foundation by doing more for them and giving them more reasons to return to NerdWallet, and we're encouraged by the progress we're making.”

Tim Chen, Co-Founder and CEO of NerdWallet
4:18 PM ET 8-K
Financial Results James Hardie Industries plc JHX

James Hardie Industries Financial Results

James Hardie reported second quarter fiscal 2027 net sales of $1.428 billion for continuing operations, a 24% increase year-over-year. The company reported net income from continuing operations of $149.8 million and reaffirmed its full-year consolidated sales and Adjusted EBITDA outlook while raising its free cash flow target to over $650 million.

Term
Q2 FY2027

“We delivered a strong second quarter, with sales from continuing operations up 24%, well above the market and at the high end of our guidance range. Adjusted EBITDA was above the guidance range, with margins expanding 450 basis points. North America fiber cement and Deck, Rail & Accessories both delivered double-digit sell-through growth, driven by consistent execution against our sales initiatives, material conversion opportunities and commercial synergies.”

Aaron Erter, CEO of James Hardie

“Halfway through the year, we are delivering on the commitments we set for fiscal 2027. While the U.S. housing market remains challenging, particularly new construction, our plan does not depend on a near-term recovery. Based on our broad set of self-help growth levers and our confidence in continuing to outperform the market, we are reaffirming our consolidated fiscal 2027 sales and Adjusted EBITDA outlook and raising our free cash flow target.”

Aaron Erter, CEO of James Hardie
4:18 PM ET Form 4
Insider Selling Everest Group, Ltd. EG

Everest Group Insider Laura J. Hay Sells $60.3K of Stock

Laura J. Hay sold 144 shares of Everest Group, Ltd. at $418.78 a share, worth $60.3K in total on Nov 4, 2026. Shares held after the trade: 1,770 (-7.5%).

Value
$60.3K
Shares
144
Price
$418.78
Holding change
-7.5%
Trade date
Nov 4, 2026
4:18 PM ET 8-K
Financial Results Arteris, Inc. AIP

Arteris Financial Results

Arteris reported record Q3 2026 revenue of $25.8 million, a 48% year-over-year increase, driven by strong demand for AI infrastructure and edge computing semiconductor technology. The company surpassed 1,000 confirmed design starts since inception and reported that Annual Contract Value plus royalties reached $103.8 million.

Term
Q3 2026

“In the third quarter, Arteris delivered another set of record results, including Annual Contract Value plus royalties of $103.8 million, up 39% year-over-year, and record revenue of $25.8 million, representing an increase of 48%, along with new highs in royalties and Remaining Performance Obligations.”

K. Charles Janac, President and Chief Executive Officer

“As the demand for increasingly sophisticated, high-performance, power-efficient, safe, and secure silicon continues to grow, we believe Arteris remains well positioned to help customers accelerate innovation and bring their next-generation products to market”

K. Charles Janac, President and Chief Executive Officer
4:18 PM ET Form 4
Insider Selling AtriCure, Inc. ATRC

AtriCure Chief Technical Officer Salvatore Privitera Sells $546K of Stock

Salvatore Privitera, Chief Technical Officer, sold 8,404 shares of AtriCure, Inc. at $65.00 a share, worth $546K in total on Nov 4, 2026. Shares held after the trade: 134,341 (-5.9%).

Value
$546K
Shares
8,404
Price
$65.00
Role
Chief Technical Officer
Holding change
-5.9%
Trade date
Nov 4, 2026
4:18 PM ET 8-K
Financial Results Shoulder Innovations, Inc. SI

Shoulder Innovations Financial Results

Shoulder Innovations reported Q3 2026 revenue of $16.2 million, a 38% year-over-year increase driven by higher implant system sales and surgeon adoption. The company raised its full-year 2026 revenue guidance to a range of $68 million to $70 million and highlighted the commercial launch of its N-22 humeral head.

“Our third quarter results reflect the consistency of our commercial model, as we added new surgeons ahead of plan, grew volume within our existing customer base, and kept our product roadmap moving.”

Rob Ball, CEO of Shoulder Innovations

“This performance enabled us to again raise our outlook for the full year, and confirmed our conviction regarding our ability to grow market share through a differentiated approach to shoulder surgical care.”

Rob Ball, CEO of Shoulder Innovations
4:18 PM ET 8-K
Financial Results SkinHealth Systems Inc. SKIN

SkinHealth Systems Financial Results

SkinHealth Systems reported third quarter 2026 financial results, with net sales of $69.2 million and a significantly narrowed net loss of $0.9 million compared to $11.0 million in the prior year. The company highlighted a return to growth in consumables and improved adjusted EBITDA margins as it executes on strategic priorities for its flagship Hydrafacial brand.

Term
Q3 2026

“Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction.”

Pedro Malha, President and Chief Executive Officer
4:18 PM ET 8-K
Financial Results Sweetgreen, Inc. SG

Sweetgreen Financial Results

Sweetgreen reported third quarter 2026 revenue of $176.0 million, a 2.1% increase year-over-year, despite a same-store sales decline of 6.4%. The company narrowed its net loss to $30.7 million compared to $36.1 million in the prior year period, though restaurant-level profit margins compressed to 10.4% due to traffic deleverage and higher labor costs.

Term
Q3 2026

“We believe our Sweet Growth Transformation Plan is beginning to take hold, with sales improving through the quarter and positive comparable sales in October, primarily driven by transaction growth. We are confident in our plan to build on this progress by investing in our restaurant teams, delivering a consistently great customer experience and expanding our menu with bold, craveable food. Our focus is clear: bring more customers into sweetgreen and give them more reasons to come back.”

Jonathan Neman, Co-Founder and Chief Executive Officer
4:18 PM ET 8-K
Business Update Inovio Pharmaceuticals, Inc. INO

Inovio Pharmaceuticals Business Update

INOVIO Pharmaceuticals provided a preliminary financial update for the quarter ended September 30, 2026, estimating its cash, cash equivalents, and short-term investments at approximately $48.4 million. This disclosure serves as a selective operational update ahead of its full quarterly financial report.

Term
Q3 2026
4:18 PM ET 10-Q
Financial Results Planet Fitness, Inc. PLNT

Planet Fitness Q3 2026 Results: Net Income $52M, Down 11.6% YoY

Planet Fitness reported a decrease in cash and cash equivalents to $310.2 million as of September 30, 2026, compared to $345.7 million at year-end 2025. The company maintained a strong asset base with total current assets of $604.4 million and significant investments in property, equipment, and right-of-use assets totaling over $1 billion.

Key figure
Net income $52M · -11.6% YoY
4:18 PM ET 10-Q
Financial Results Enliven Therapeutics, Inc. ELVN

Enliven Therapeutics Q3 2026 Results: Net Loss of $27.7M, Loss Widens

Enliven Therapeutics reported a significant increase in liquidity, with cash, cash equivalents, and marketable securities totaling approximately $884.4 million as of September 30, 2026, compared to $462.6 million at year-end 2025. The company is advancing its clinical pipeline, specifically relcobatinib (ELVN-001), and preparing for the ENABLE-2 Phase 3 pivotal trial.

Key figure
Net loss $27.7M
4:18 PM ET 10-Q
Financial Results Westwood Holdings Group Inc WHG ▶ Call

Westwood Holdings Group Q3 2026 Results: Net Income $3.12M, Down 16.3% YoY

Westwood Holdings Group reported total revenues of $26.6 million for the third quarter of 2026, an increase from $24.3 million in the prior year, driven by higher asset-based advisory fees. Net income attributable to the company was $3.1 million for the quarter, down slightly from $3.7 million in 2025 due to increased employee compensation and professional services expenses.

Key figure
Net income $3.12M · -16.3% YoY
4:18 PM ET 8-K
Financial Results Westwood Holdings Group Inc WHG

Westwood Holdings Group Financial Results

Westwood Holdings Group reported Q3 2026 revenue of $26.6 million and net income of $3.1 million, driven by growth in its ETF platform and private capital business. The company also declared a quarterly cash dividend of $0.15 per share and highlighted the launch of its PWRX ETF on the Texas Stock Exchange.

Term
Q3 2026

“We're proud of the progress we made this quarter, highlighted by the launch of our Enhanced Power and Infrastructure ETF (PWRX) as the first new ETF on the Texas Stock Exchange and our ETF platform surpassed $430 million in assets at quarter-end. With continued momentum in our private capital business and a robust pipeline across our Value, Managed Investment Solutions and Energy strategies, we believe Westwood is well positioned to deliver long-term value for clients and shareholders.”

Brian Casey, Westwood’s CEO
4:17 PM ET 8-K
Financial Results Puma Biotechnology, Inc. PBYI

Puma Biotechnology Financial Results

Puma Biotechnology reported Q3 2026 financial results with total product revenue of $54.1 million, driven by sales of NERLYNX. The company reported GAAP net income of $6.0 million and raised its full-year 2026 net income guidance while continuing to advance its alisertib clinical development programs.

Term
Q3 2026

“Third quarter U.S. NERLYNX sales were positively impacted by increased year-over-year demand and were negatively impacted by higher than expected gross to net due to an increase in Medicaid and 340B sales, as well as a delay in sales to Puma’s ex-U.S. commercial partners that shifted from the third quarter to the fourth quarter.”

Alan H. Auerbach, Chairman, Chief Executive Officer and President

“We continue to anticipate increased year-over-year demand for NERLYNX, while we continue to advance alisertib across our ALISCA® clinical development programs.”

Alan H. Auerbach, Chairman, Chief Executive Officer and President
4:17 PM ET 8-K
Financial Results Eton Pharmaceuticals, Inc. ETON

Eton Pharmaceuticals Financial Results

Eton Pharmaceuticals reported record Q3 2026 revenue of $57.9 million, representing 158% year-over-year growth and surpassing its $200 million annualized revenue run rate goal ahead of schedule. The company achieved a 49% Adjusted EBITDA margin and raised its full-year 2026 revenue guidance to over $175 million.

Term
Q3 2026

“Eton delivered another record quarter, with revenue of $57.9 million, up 158% year over year, and surpassed our $200 million annualized revenue run rate goal five quarters ahead of schedule. The team also demonstrated exceptional operational execution, significantly expanding margins, and delivering an adjusted EBITDA margin of 49%.”

Sean Brynjelsen, CEO of Eton Pharmaceuticals

“We have also made transformational improvements to our pipeline in recent months with ASN-001 for infantile hemangiomas, and ET-900, our new program evaluating mecasermin in infantile and epileptic spasms.”

Sean Brynjelsen, CEO of Eton Pharmaceuticals
4:17 PM ET Form 4
Insider Selling Rithm Capital Corp. RITM

Rithm Capital CFO Nicola Santoro Jr. Sells $951K of Stock

Nicola Santoro Jr., CFO, sold 100,000 shares of Rithm Capital Corp. at $9.51 a share, worth $951K in total on Nov 4, 2026. Shares held after the trade: 81,281 (-55.2%).

Value
$951K
Shares
100,000
Price
$9.51
Role
CFO
Holding change
-55.2%
Trade date
Nov 4, 2026
4:17 PM ET 8-K
Financial Results A10 Networks, Inc. ATEN

A10 Networks Financial Results

A10 Networks reported record third quarter 2026 revenue of $91.5 million, up 22.6% year-over-year, driven by broad-based demand for networking and security solutions. The company updated its full-year 2026 revenue growth guidance to 16% and set a long-term 2029 revenue target of $500 million. Additionally, the Board approved a quarterly cash dividend of $0.06 per share.

Term
Q3 2026

“Third quarter revenue increased 22.6% year-over-year to record quarterly levels, supported by broad-based customer demand, with our business model enabling record non-GAAP operating and net income levels.”

Dhrupad Trivedi, President and Chief Executive Officer of A10 Networks

“Our progress, expanding global opportunity and continued execution give us confidence in setting long-term targets of $500 million in annual revenue through organic growth and $2.00 in annual non-GAAP EPS for fiscal year 2029.”

Dhrupad Trivedi, President and Chief Executive Officer of A10 Networks
4:17 PM ET 8-K/A
M&A Deal Somnigroup International Inc. SGI

Somnigroup International M&A Deal with Leggett & Platt, Incorporated

Somnigroup International Inc. completed its acquisition of Leggett & Platt, Incorporated, which became a direct, wholly owned subsidiary. The transaction was structured as an all-stock merger where Leggett & Platt shareholders received 0.1455 shares of Somnigroup common stock for each share held. This filing serves as an amendment to provide required historical and pro forma financial statements following the closing of the deal.

Counterparty
Leggett & Platt, Incorporated
4:17 PM ET 8-K
Financial Results Adicet Bio, Inc. ACET

Adicet Bio Financial Results

Adicet Bio reported third quarter 2026 financial results and provided updates on its clinical pipeline, including positive Phase 1 data for prula-cel in systemic lupus erythematosus. The company ended the quarter with $204.4 million in cash and cash equivalents, providing a projected runway into the second half of 2027.

Term
Q3 2026

“The growing body of evidence for prula-cel continues to strengthen our conviction in its potential to generate meaningful, lasting remissions for patients living with SLE, including those with LN and extra renal SLE. The compelling efficacy observed following complete discontinuation of immunosuppressants, together with evidence of a deep immune reset and a favorable safety profile supporting outpatient administration, reinforce the potential for prula-cel to meaningfully change the treatment paradigm for lupus patients.”

Chen Schor, President and Chief Executive Officer of Adicet Bio
4:17 PM ET 8-K
Financial Results Kodiak AI, Inc. KDK

Kodiak AI Financial Results

Kodiak AI reported third-quarter 2026 results, highlighting that its Autonomy Readiness Measure reached 99% ahead of its targeted year-end unsupervised autonomous long-haul launch. The company secured a landmark binding agreement with DTL Transport for 75 customer-owned unsupervised autonomous trucks and named IKEA Supply as its first long-haul launch partner.

“We are approaching a defining moment for Kodiak as we advance toward our targeted year-end unsupervised autonomous long-haul launch, with our Autonomy Readiness Measure now at 99%. Our landmark binding agreement with DTL Transport to deploy the Kodiak Driver in 75 customer-owned and operated unsupervised autonomous trucks represents a significant commercial commitment to our Driver-as-a-Service model and demonstrates growing customer confidence in Kodiak's technology and commercial capabilities.”

Don Burnette, Founder and Chief Executive Officer
4:17 PM ET 10-Q
Financial Results Assurant, Inc. AIZ

Assurant Q3 2026 Results: Net Income $275M, Up 3.6% YoY

Assurant, Inc. reported a net income of $275.2 million for the third quarter of 2026, up from $265.6 million in the prior year period. Total revenues grew to $3.53 billion, driven by increases in net earned premiums and fee income, while the company maintained a strong balance sheet with total assets of $36.49 billion.

Key figure
Net income $275M · +3.6% YoY
4:17 PM ET 10-Q
Financial Results Adicet Bio, Inc. ACET

Adicet Bio Q3 2026 Results: Net Loss of $18.9M, Loss Narrows

Adicet Bio, Inc. is a clinical-stage biotechnology company focused on gamma delta T cell therapies for autoimmune diseases and cancer, with its lead candidate prula-cel (ADI-001) currently in Phase 1 trials. The company reported 9,361,596 shares of common stock outstanding as of November 3, 2026, and highlighted significant risks including the need for substantial additional financing and reliance on third-party manufacturing.

Key figure
Net loss $18.9M
4:17 PM ET 8-K
Financial Results Citizens, Inc. CIA

Citizens Financial Results

Citizens, Inc. reported third quarter 2026 financial results, highlighted by a 7% increase in direct insurance premiums to $50 million. The company reported a net loss of $0.4 million compared to a net income of $2.4 million in the prior year period, primarily due to higher future policy benefit reserves and a tough comparison against reserve releases in 2025.

“Premium growth, distribution expansion, and cash generation all continued to strengthen. Our third-quarter results show the continued momentum of our domestic insurance business. Overall direct premiums grew 7% to $50 million, led by a 9% increase in direct first year premiums, as our final expense sales and expanding domestic distribution continued to build our in-force block.”

Jon Stenberg, President and Chief Executive Officer

“Our announcement to invest in a modern technology ecosystem is an important step in Citizens' long-term growth strategy. By moving to third-party, cloud-based platforms, we are strengthening our insurance processing, underwriting, and policy administration capabilities.”

Jon Stenberg, President and Chief Executive Officer
4:17 PM ET 8-K
Financial Results Mach Natural Resources LP MNR

Mach Natural Resources Financial Results

Mach Natural Resources LP reported Q3 2026 financial results with total revenue of $319 million and net income of $10 million. The company averaged net production of 147 Mboe/d and declared a quarterly cash distribution of $0.22 per common unit. Management highlighted a disciplined reinvestment rate and plans to optimize the 2027 outlook around its Oswego oil play.

Term
Q3 2026

“Mach’s results are the reflection of a company built to deliver the highest possible cash distributions while maintaining a disciplined reinvestment rate, a lean cost structure and a strong balance sheet.”

Tom L. Ward, Chief Executive Officer

“The durable asset base we have built since 2018 through nearly two dozen disciplined acquisitions will continue to reward our unitholders. With 2.8 million acres and years of high-quality inventory across three world-class basins, we have optimized our 2027 plan around the favorable oil outlook.”

Tom L. Ward, Chief Executive Officer
4:17 PM ET 10-Q
Financial Results Redwire Corp RDW ▶ Call

Redwire Q3 2026 Results: Net Loss of $23.2M, Loss Narrows

Redwire Corp reported 250,219,316 shares of common stock outstanding as of November 2, 2026. The filing highlights risks related to the integration of Edge Autonomy, reliance on U.S. government contracts, and the impact of macroeconomic conditions on its evolving space technology business.

Key figure
Net loss $23.2M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.